Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Data are from the most recent national surveys available in each country (see [Table GPS-4] in the 2005 statistical bulletin).
Some countries use a slightly different age range to the EMCDDA standard age range for young adults. Variations in age ranges may to a small extent account for disparities between countries.
Denmark: 2000; 16-34 y. n=4141
Germany: 2003; 18-34 y. n=3775
Estonia: 2003; 15-34 y. n=646
Greece: 2004; 15-34 y. n=2620
Spain: 2001; 15-34 y. n=6915
France: 2002; 15-34 y. n=724
Ireland: 2002/03; 15-34 y. n=
Italy: 2003; 15-34 y. n=5231
Cyprus: 2003; 15-34 y. n=580
Latvia: 2003; 15-34 y. n=
Hungary: 2003; 18-34 y. n=2319
Netherlands: 2000/01; 15-34 y. n=6687
Poland: 2002; 16-34 y. n=
Portugal: 2001; 15-34 y. n=6406
Slovakia: 2002; 18-34 y. n=
Finland: 2002; 15-34 y. n=1240
UK (E&W): 2003/04; 16-34 y. n=8590
Norway: 1999; 15-34 y. n=794
Source:
Reitox national reports (2004), taken from population surveys, reports or scientific articles. See also [Table GPS-0] in the 2005 statistical bulletin.